← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2013Last known activity
Jul 31, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (6 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT05446480Lead sponsorN/AJul 31, 2022
- NCT05446480Overall official - principal investigatorN/AJul 31, 2022
- NCT03281655CollaboratorPhase 2Mar 31, 2020
- NCT02112721CollaboratorPhase 4May 1, 2014
- NCT01958593Overall official - principal investigatorPhase 2Sep 1, 2013
Details
- Last known activity
- Jul 31, 2022